Milos Miljkovic

CIK: 0002000282

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (55.6%)

Position reduction

Option Exercises (M)2 (22.2%)

Derivative conversions

Awards (A)2 (22.2%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RNAC

Cartesian Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

RNAC
Cartesian Therapeutics, Inc.
Jan 6, 2026
Sale(S)
Direct
3.6K shares at avg. $6.82$24K
RNAC
Cartesian Therapeutics, Inc.
Jan 2, 2026
Award(A)
Direct
27K shares-
RNAC
Cartesian Therapeutics, Inc.
Jan 6, 2025
Sale(S)
Direct
948 shares at avg. $16.83$16K
RNAC
Cartesian Therapeutics, Inc.
Jan 3, 2025
Sale(S)
Direct
932 shares at avg. $16.72$16K
RNAC
Cartesian Therapeutics, Inc.
Jan 2, 2025
Award(A)
Direct
19K shares-
RNAC
Cartesian Therapeutics, Inc.
Nov 15, 2024
Sale(S)
Direct
20K shares at avg. $17.14$343K
RNAC
Cartesian Therapeutics, Inc.
Nov 15, 2024
Exercise(M)
Direct
20K shares at avg. $3.23$65K
RNAC
Cartesian Therapeutics, Inc.
Nov 14, 2024
Sale(S)
Direct
35K shares at avg. $16.13$565K
RNAC
Cartesian Therapeutics, Inc.
Nov 14, 2024
Exercise(M)
Direct
35K shares at avg. $3.23$113K

		Type	Shares	Price		Ownership
Jan 6, 2026	RNAC Cartesian Therapeutics, Inc.	Sale(S)	3,573	$6.82	$24,367	Direct
Jan 2, 2026	RNAC Cartesian Therapeutics, Inc.	Award(A)	27,000	-	$0	Direct
Jan 6, 2025	RNAC Cartesian Therapeutics, Inc.	Sale(S)	948	$16.83	$15,957	Direct
Jan 3, 2025	RNAC Cartesian Therapeutics, Inc.	Sale(S)	932	$16.72	$15,585	Direct
Jan 2, 2025	RNAC Cartesian Therapeutics, Inc.	Award(A)	19,000	-	$0	Direct
Nov 15, 2024	RNAC Cartesian Therapeutics, Inc.	Sale(S)	20,000	$17.14	$342,888	Direct
Nov 15, 2024	RNAC Cartesian Therapeutics, Inc.	Exercise(M)	20,000	$3.23	$64,600	Direct
Nov 14, 2024	RNAC Cartesian Therapeutics, Inc.	Sale(S)	35,000	$16.13	$564,645	Direct
Nov 14, 2024	RNAC Cartesian Therapeutics, Inc.	Exercise(M)	35,000	$3.23	$113,050	Direct

1-9 of 9 transactions

About Miljkovic Milos

Miljkovic Milos (SEC CIK 0002000282) files insider reports with the SEC as Chief Medical Officer of Cartesian Therapeutics, Inc. (RNAC).

Signal8 holds 5 ownership filings by Miljkovic Milos, all Form 4s, filed between Nov 18, 2024 and Jan 8, 2026. Those filings report 9 transactions, from Nov 14, 2024 to Jan 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Miljkovic Milos's filings is in FREDERICK, MD.

Recent filings by Miljkovic Milos

Jan 6, 2026: Open-market sale of RNAC shares (Form 4, code S).
Jan 2, 2026: Grant or award of RNAC shares (Form 4, code A).
Jan 6, 2025: Open-market sale of RNAC shares (Form 4, code S).
Jan 3, 2025: Open-market sale of RNAC shares (Form 4, code S).
Jan 2, 2025: Grant or award of RNAC shares (Form 4, code A).

Other insiders filing for Cartesian Therapeutics, Inc. (RNAC)

Hoge Elizabeth, 10% Owner
Kalayoglu Murat, 10% Owner
Singer Michael, Director
Brunn Carsten, President and CEO
Davis Blaine, Chief Financial Officer
DeSilva Nishan M, Director

How to read Form 4 transaction codes